NCT04184479

Brief Summary

This study evaluates weight loss effect of the method LEVA by Bertz et al in subjects with overweight or obesity that are remitted to Primärvårdens Dietistenhet.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
14mo left

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Dec 2020Aug 2027

First Submitted

Initial submission to the registry

November 24, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 3, 2019

Completed
1 year until next milestone

Study Start

First participant enrolled

December 2, 2020

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

November 25, 2024

Status Verified

November 1, 2024

Enrollment Period

5.7 years

First QC Date

November 24, 2019

Last Update Submit

November 21, 2024

Conditions

Keywords

overweightrandomized controlled trialobesityweight lossweight loss maintenance

Outcome Measures

Primary Outcomes (3)

  • Change of weight between intervention group and placebo

    Weight in kg measured at visits

    From baseline and 12 weeks

  • Change of weight between intervention group and placebo

    Weight in kg measured at visits

    From baseline and 1 year

  • Change of weight between intervention group and placebo

    Weight in kg measured at visits

    From baseline and 2 year

Secondary Outcomes (12)

  • Gender differences in weight loss results

    From baseline to 12 weeks

  • Gender differences in weight loss results

    From baseline to 1 year

  • Gender differences in weight loss results

    From baseline to 2 year

  • Age differences in weight loss results

    From baseline to 12 weeks

  • Age differences in weight loss results

    From baseline to 1 years

  • +7 more secondary outcomes

Study Arms (2)

A-LEVAmetoden by Bertz et al

ACTIVE COMPARATOR

Individual dietary advices for weight loss, based on the participants' food record of 4 consecutive days aimed to achieve an energy intake reduction of 500 kcal/d with a nutrient composition according to the Nordic Nutrition Recommendations. Follow up visits after 3 months, 1 year and 2 years after baseline. Follow up by electronic platform every other week until 3 months after baseline and each month after 3 months until 1 year after baseline.

Behavioral: LEVAmethod by Bertz et al

B-Ordinary treatment

PLACEBO COMPARATOR

Dietary advices for weight loss aimed to achieve calorie restriction. Follow up visits after 3 months, 1 year and 2 years after baseline. Additional visits, up to 4 times in the first year after baseline.

Behavioral: LEVAmethod by Bertz et al

Interventions

Ordinary treatment

Also known as: Ordinary treatment
A-LEVAmetoden by Bertz et alB-Ordinary treatment

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI 27 ≤ 35
  • age 18-75 år

You may not qualify if:

  • difficulty understanding Swedish, spoken or read
  • does not manage/want to handle digital Tools
  • the remittance was addressed to Primärvårdens Dietistenhet at wrong premises and the patient should be treated elsewhere.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Västra Götalandsregionen

Gothenburg, Sweden

RECRUITING

MeSH Terms

Conditions

OverweightObesityWeight Loss

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Officials

  • Else Johansson

    Västra Götalandsregionen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2019

First Posted

December 3, 2019

Study Start

December 2, 2020

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2027

Last Updated

November 25, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations